Die Veröffentlichung des 10. IMI2 -Aufrufs ist für Oktober 2016 geplant.
Am Mittwoch, dem 21. September 2016, wird von 10:30 bis 12:00 Uhr ein Webinar zum zehnten Aufruf 2016 der Innovative Medicines Initiative 2 (IMI2) angeboten. Die Teilnahme am Webinar ist kostenlos. Weitere Informationen und die Möglichkeit zur Anmeldung finden Sie hier: Webinar auf der IMI2-Website
Den Entwurf der Ausschreibungstexte finden Sie hier: Ausschreibungstexte auf der IMI2-Website. Mögliche Themen:
- Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
- How big data could support better diagnosis and treatment outcomes for prostate cancer
Note: topic forms part of the IMI Big Data for Better Outcomes (BD4BO) programme - Improving the care of patients suffering from acute or chronic pain
Note: this topic consists of three subtopics:- A : Using patient reported outcome measures to improve the management of acute and chronic pain (PROMs)
- B : Improving the translatability of pharmacodynamic biomarkers in pain pathways of healthy subjects and preclinical species (BIOM)
- C: Improving translation in chronic pelvic pain (PCC)
- Creation of a pan-European paediatric clinical trials network
- Biomanufacturing 2020: Development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
- Unlocking the solute carrier gene-family for effective new therapies
- Enhanced patient voice in medicines lifecycle – feedback wanted (see below)
- Precision medicines approaches in autism spectrum disorders